BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30664924)

  • 1. p38 MAPK-dependent alphaB-crystallin phosphorylation in Alzheimer's disease-like pathology in OXYS rats.
    Muraleva NA; Kolosova NG; Stefanova NA
    Exp Gerontol; 2019 May; 119():45-52. PubMed ID: 30664924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of αB-crystallin in the myocardium: Analysis of relations with aging and cardiomyopathy.
    Muraleva NA; Devyatkin VA; Kolosova NG
    Exp Gerontol; 2017 Sep; 95():26-33. PubMed ID: 28502773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Changes in Neurotrophic Supplementation on Development of Alzheimer's Disease-Like Pathology in Oxys Rats.
    Rudnitskaya EA; Kolosova NG; Stefanova NA
    Biochemistry (Mosc); 2017 Mar; 82(3):318-329. PubMed ID: 28320273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer's Disease-Like Pathology in OXYS Rats.
    Muraleva NA; Stefanova NA; Kolosova NG
    Antioxidants (Basel); 2020 Jul; 9(8):. PubMed ID: 32731533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P38 MAPK Signaling in the Retina: Effects of Aging and Age-Related Macular Degeneration.
    Muraleva NA; Kolosova NG
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytic α7 Nicotinic Receptor Activation Inhibits Amyloid-β Aggregation by Upregulating Endogenous αB-crystallin through the PI3K/Akt Signaling Pathway.
    Ren Z; Yang M; Guan Z; Yu W
    Curr Alzheimer Res; 2019; 16(1):39-48. PubMed ID: 30345917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoprotective Effect of SkQ1, Visomitin Eye Drops, Is Associated with Suppression of P38 MAPK and ERK1/2 Signaling Pathways Activity.
    Muraleva NA; Zhdankina AA; Fursova AZ; Kolosova NG
    Biochemistry (Mosc); 2024 Feb; 89(2):201-211. PubMed ID: 38622090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats.
    Stefanova NA; Maksimova KY; Rudnitskaya EA; Muraleva NA; Kolosova NG
    BMC Genomics; 2018 Feb; 19(Suppl 3):75. PubMed ID: 29504901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease.
    Stefanova NA; Kozhevnikova OS; Vitovtov AO; Maksimova KY; Logvinov SV; Rudnitskaya EA; Korbolina EE; Muraleva NA; Kolosova NG
    Cell Cycle; 2014; 13(6):898-909. PubMed ID: 24552807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer's Disease: A Study in Senescence-Accelerated OXYS Rats.
    Muraleva NA; Kolosova NG; Stefanova NA
    Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34208998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition.
    Savage MJ; Lin YG; Ciallella JR; Flood DG; Scott RW
    J Neurosci; 2002 May; 22(9):3376-85. PubMed ID: 11978814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1.
    Stefanova NA; Muraleva NA; Skulachev VP; Kolosova NG
    J Alzheimers Dis; 2014; 38(3):681-94. PubMed ID: 24047616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of Ser45 and Ser59 of αB-crystallin and p38/extracellular regulated kinase activity determine αB-crystallin-mediated protection of rat brain astrocytes from C2-ceramide- and staurosporine-induced cell death.
    Li R; Reiser G
    J Neurochem; 2011 Aug; 118(3):354-64. PubMed ID: 21615407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of hippocampal neurogenesis during development of Alzheimer's disease-like pathology in OXYS rats.
    Rudnitskaya EA; Kozlova TA; Burnyasheva AO; Kolosova NG; Stefanova NA
    Exp Gerontol; 2019 Jan; 115():32-45. PubMed ID: 30415068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.
    Tyumentsev MA; Stefanova NA; Muraleva NA; Rumyantseva YV; Kiseleva E; Vavilin VA; Kolosova NG
    J Alzheimers Dis; 2018; 63(3):1075-1088. PubMed ID: 29710722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective role of P38 MAPK during myocardial infarction via parallel activation of α-crystallin B and Nrf2.
    Mitra A; Ray A; Datta R; Sengupta S; Sarkar S
    J Cell Physiol; 2014 Sep; 229(9):1272-82. PubMed ID: 24464634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p38 mitogen-activated protein kinase signaling pathway is involved in regulating low-density lipoprotein receptor-related protein 1-mediated β-amyloid protein internalization in mouse brain.
    Ma KG; Lv J; Hu XD; Shi LL; Chang KW; Chen XL; Qian YH; Yang WN; Qu QM
    Int J Biochem Cell Biol; 2016 Jul; 76():75-86. PubMed ID: 27163530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorative effects of SkQ1 eye drops on cataractogenesis in senescence-accelerated OXYS rats.
    Rumyantseva YV; Ryabchikova EI; Fursova AZ; Kolosova NG
    Graefes Arch Clin Exp Ophthalmol; 2015 Feb; 253(2):237-48. PubMed ID: 25267419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties.
    Tikhonova MA; Amstislavskaya TG; Belichenko VM; Fedoseeva LA; Kovalenko SP; Pisareva EE; Avdeeva AS; Kolosova NG; Belyaev ND; Aftanas LI
    BMC Neurosci; 2018 Apr; 19(Suppl 1):13. PubMed ID: 29745864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Neuronal Death in the Cerebral Cortex during Aging and Development of Alzheimer's Disease-Like Pathology in Rats.
    Telegina DV; Suvorov GK; Kozhevnikova OS; Kolosova NG
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.